Cost-effectiveness modelling of sequential biologic strategies for the treatment of moderate to severe rheumatoid arthritis in Finland.
about
Modeling rheumatoid arthritis using different techniques - a review of model construction and results.Investigating the value of abatacept in the treatment of rheumatoid arthritis: a systematic review of cost-effectiveness studies.Current perspectives on tocilizumab for the treatment of rheumatoid arthritis: a reviewClinical Outcomes and Biologic Costs of Switching Between Tumor Necrosis Factor Inhibitors in US Veterans with Rheumatoid Arthritis.Cost-effectiveness of abatacept for moderate-to-severe rheumatoid arthritis.Including adverse drug events in economic evaluations of anti-tumour necrosis factor-α drugs for adult rheumatoid arthritis: a systematic review of economic decision analytic models.How to select the right cost-effectiveness model? : A systematic review and stepwise approach for selecting a transferable health economic evaluation model for rheumatoid arthritis.Modelling outcomes of complex treatment strategies following a clinical guideline for treatment decisions in patients with rheumatoid arthritis.Cost-effectiveness of biologic compared with conventional synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis: a Register study.
P2860
Q35851012-3DD20434-6E4B-4D6C-A25F-FF18F545E73DQ36931485-4B00A4EB-6B51-438C-B221-CAF7317FCABAQ36996859-82B71AEB-D602-48DD-A25A-153FD02D2766Q37143744-AD17F8F5-E93C-4823-9AC9-7A8D7C6A94CAQ38170177-2B4DC7E1-E577-491D-B020-90D101D4759FQ38171360-B0517163-9E7B-47F8-93A9-B22C6BE32076Q38185992-E28DDC29-7FF7-4F77-BF82-C847076ABB95Q39168790-E6B50C77-2A7D-462D-8E70-5EDE6CC52C3DQ39646869-A5BC0D20-4219-4949-AB42-88C198C1851E
P2860
Cost-effectiveness modelling of sequential biologic strategies for the treatment of moderate to severe rheumatoid arthritis in Finland.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Cost-effectiveness modelling o ...... eumatoid arthritis in Finland.
@ast
Cost-effectiveness modelling o ...... eumatoid arthritis in Finland.
@en
type
label
Cost-effectiveness modelling o ...... eumatoid arthritis in Finland.
@ast
Cost-effectiveness modelling o ...... eumatoid arthritis in Finland.
@en
prefLabel
Cost-effectiveness modelling o ...... eumatoid arthritis in Finland.
@ast
Cost-effectiveness modelling o ...... eumatoid arthritis in Finland.
@en
P2093
P2860
P1476
Cost-effectiveness modelling o ...... eumatoid arthritis in Finland.
@en
P2093
A Beresniak
H Blåfield
K Puolakka
K Sennfalt
R Luosujärvi
R Peltomaa
T Leikola-Pelho
P2860
P356
10.2174/1874312901206010038
P577
2012-04-26T00:00:00Z